The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.00
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 2.00 (50.00%)
Open: 5.00
High: 5.00
Low: 5.00
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of annual report and notice of AGM

5 Jul 2023 07:00

RNS Number : 9488E
Braveheart Investment Group plc
05 July 2023
 

5 July 2023

Braveheart Investment Group plc

("Braveheart", the "Company" or the "Group")

 

Posting of annual report and accounts, notice of AGM and

proposed amendment to investment strategy

 

Braveheart Investment Group (AIM: BRH), announces that the Company's annual report and accounts for the year ended 31 March 2023, which incorporates notice of the Company's 2023 Annual General Meeting ("AGM") will be posted to shareholders today and will be available to download from the Company's website at www.braveheartgroup.co.uk.

 

The AGM will be held on 28 July 2023 at 10.30 am at the office of China Ventures Ltd, Unit 2, Common Farm, Common Lane, Mappleborough Green, Warwickshire, B80 7DP.

 

Proposed amendments to the Group's investment strategy

 

The AGM notice contains a resolution (the "Investment Strategy Resolution") to permit the Directors to replace the Company's investment strategy (the "Investment Strategy") as set out in part 1 of the Company's admission document dated 27 March 2007, which determines the permitted business and strategy of the Company.

 

The proposed new Investment Strategy is set out below:

 

The Group's strategy is to invest in early and later-stage businesses, primarily in the technology sector, but it will also consider opportunities in other sectors that are knowledge intensive, such as healthcare and professional services.

 

The Group will target investments in both unlisted and listed companies, where there is potential for significant growth. Investments are expected to be mainly in the form of equity and equity-related instruments, including convertible debt instruments in certain circumstances.

 

The Group may acquire investments directly or by way of holdings in intermediate holding or subsidiary entities. The Group might also invest in limited liability partnerships and other forms of legal entity. Where possible, the Group will seek investor protection rights, as determined by the Board.

 

The Group may offer its Ordinary Shares in exchange for shares in investee businesses in addition to a cash investment in such businesses.

 

For unlisted company investments, the Group targets companies at different stages of development, ranging from those which are just starting to trade to those which are expecting to achieve an IPO in the short term, thus providing portfolio diversification. These investments will typically involve active investment management.

 

The Group, where appropriate and deemed by the Board to be in the Group's best interests, may seek a position on the boards of unlisted investee companies. The Group where appropriate, will assist the board and management of investee companies, including helping to scale management teams, informing strategy and assisting with future financing.

 

For listed company investments, the Group targets investments where the Board considers the shares are undervalued but there are opportunities for significant growth. These investments will typically involve passive investment management, although the Board may take a more active approach if it considers there is a need to effect change.

 

Braveheart may occasionally invest in companies that are in rescue or distress situations where a value-creating opportunity has been identified. The Group does not have any maximum exposure limits but will generally take a minority stake in a business and look for investments where there is a good prospect of an exit in a two-to-five-year time period.

 

As risk reduces, the Group may increase its investment in subsequent rounds of funding and, as those businesses grow, may find itself holding a controlling interest in some trading companies. However, in such instances the Board will ensure that there is sufficient separation between the Group and the investee company so that the investee company does not become a trading company of the Group.

 

Full details of the proposed amendments to the Investment Strategy are set out in the explanatory notes to the notice of AGM. Should the Investment Strategy Resolution not be passed at the AGM, the Company will not be able to make the proposed amendments to the Investment Strategy. A further announcement will be made on conclusion of the AGM.

 

For further information:

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

Viv Hallam, Executive Director

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

James Reeve / George Payne

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOANKQBBNBKDCOK
Date   Source Headline
12th Nov 20087:00 amRNSSenior Management Change
16th Oct 20087:00 amRNSDirectorate Change
1st Oct 20087:00 amRNSTrading Statement
12th Sep 20084:43 pmRNSOffer Update
10th Sep 20082:27 pmRNSResult of AGM
4th Sep 200811:30 amRNSRule 8.3- Braveheart Inv. Grp
4th Sep 200811:22 amRNSRule 8.3- Braveheart Inv. Grp
26th Aug 200810:07 amRNSEPT Disclosure
21st Aug 20089:26 amRNSEPT Disclosure
18th Aug 20087:00 amRNSNotice of AGM & Directorate C
11th Aug 200810:26 amRNSEPT Disclosure
28th Jul 20087:00 amRNSGrant of Options
18th Jul 20083:09 pmRNSResponse RE Angle Offer
18th Jul 20087:00 amRNSStatement re possible offer
16th Jul 20089:17 amRNSEPT Disclosure
11th Jul 20081:05 pmRNSStatement re. announcement
11th Jul 20088:10 amRNSOffer Update
25th Jun 20087:00 amRNSPreliminary Results
23rd Jun 20081:58 pmRNSFurther re notice of results
23rd Jun 20087:01 amRNSCommercialisation Agreement
23rd Jun 20087:00 amRNSInvestment in IM-Sense
16th Jun 20087:00 amRNSNotice of Results
13th Jun 200812:27 pmRNSErnst and Young Award
5th Jun 20087:00 amRNSDirectorate Change
14th Apr 20087:00 amRNSInvestment in Spiral Gateway
10th Apr 200811:15 amRNSFurther re possible offer
10th Apr 20087:00 amRNSInvestment in Cascade
9th Apr 20084:24 pmRNSPossible Offer
7th Apr 20087:00 amRNSInvestment In Conjunct
2nd Apr 20087:01 amRNSInvestment in AppShare
13th Feb 20087:00 amRNSInvestment
8th Feb 20087:00 amRNSChange of Adviser
10th Jan 20087:00 amRNSInvestment
2nd Jan 20083:38 pmRNSChange of Adviser
3rd Dec 20077:00 amRNSInterim Results
21st Nov 20078:43 amRNSNotice of Results
1st Oct 20077:01 amRNSPortfolio Company Update
13th Sep 20077:05 amRNSResult of AGM
13th Sep 20077:01 amRNSDirectorate Change
20th Aug 20077:00 amRNSInvestment
17th Aug 20077:00 amRNSNotice of AGM/Annual Report
14th Aug 20077:00 amRNSAIM Rule 26
13th Aug 20077:00 amRNSInvestment
13th Jul 20077:00 amRNSAward of Options
19th Jun 20077:01 amRNSInvestment
18th Jun 20077:01 amRNSFinal Results
18th Jun 20077:00 amRNSFund Launch
14th Jun 20077:01 amRNSInvestment
8th Jun 20077:15 amRNSNotice of Results
4th Jun 200710:44 amRNSInvestee company flotation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.